烟台鲁银药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
141
NMPA:141
Drug Approvals
Tamsulosin Hydrochloride Sustained Release Capsules
- Product Name
- 盐酸坦索罗辛缓释胶囊
- Approval Number
- 国药准字H20253938
- Approval Date
- Apr 15, 2025
NMPA
Metoprolol Succinate Sustained-release Capsules
- Product Name
- 琥珀酸美托洛尔缓释胶囊
- Approval Number
- 国药准字H20244200
- Approval Date
- Jun 28, 2024
NMPA
Metoprolol Succinate Sustained-release Capsules
- Product Name
- 琥珀酸美托洛尔缓释胶囊
- Approval Number
- 国药准字H20244198
- Approval Date
- Jun 28, 2024
NMPA
Metoprolol Succinate Sustained-release Capsules
- Product Name
- 琥珀酸美托洛尔缓释胶囊
- Approval Number
- 国药准字H20244199
- Approval Date
- Jun 28, 2024
NMPA
Tranexamic Acid Injection
- Product Name
- 氨甲环酸注射液
- Approval Number
- 国药准字H20243925
- Approval Date
- Jun 4, 2024
NMPA
Tranexamic Acid Injection
- Product Name
- 氨甲环酸注射液
- Approval Number
- 国药准字H20243924
- Approval Date
- Jun 4, 2024
NMPA
Nifuratel Vaginal Tablets
- Product Name
- 硝呋太尔阴道片
- Approval Number
- 国药准字H20153004
- Approval Date
- Apr 9, 2024
NMPA
Sitagliptin Phosphate Tablets
- Product Name
- 磷酸西格列汀片
- Approval Number
- 国药准字H20243205
- Approval Date
- Feb 23, 2024
NMPA
Nifedipine Controlled-release Tablets
- Product Name
- 硝苯地平控释片
- Approval Number
- 国药准字H20234525
- Approval Date
- Nov 21, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
Clinical Trials
No trials found
News
No news found